Related Experiment Video
Updated: Jun 6, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Effect of antihypertensive therapy on cognitive functions of patients with hypertension
Ashok Jaiswal1, V Bhavsar, Jaykaran
1Marketing, Zydus Cedilla, Ahmedabad India.
Insights
Antihypertensive therapy improved cognitive function in newly diagnosed hypertensive patients. Three months of treatment led to increased scores in most cognitive tests, with no observed decline.
Area of Science:
- Neurology
- Cardiology
- Gerontology
Background:
- Hypertension is a known risk factor for cognitive decline.
- Antihypertensive therapy is often prescribed to manage hypertension and potentially mitigate cognitive impairment.
- Existing research presents conflicting evidence regarding the protective effects of antihypertensive drugs on cognitive function.
Purpose of the Study:
- To evaluate the cognitive status of patients recently diagnosed with hypertension.
- To assess the impact of a 3-month antihypertensive therapy regimen on cognitive functions in these patients.
Main Methods:
- Cognitive function was assessed using the PGI memory scale (PGIMS).
- Baseline cognitive scores of hypertensive patients were compared to healthy volunteers.
- Cognitive functions were re-evaluated after 3 months of antihypertensive treatment.
- Statistical analysis included unpaired t-tests for between-group comparisons and paired t-tests for pre- and post-treatment assessments.
Main Results:
- Hypertensive patients demonstrated lower mean scores across six cognitive subtests compared to the control group.
- Following 3 months of antihypertensive therapy, significant improvements were observed in five cognitive subtests.
- Four of the improved subtests corresponded to those initially showing deficits at baseline.
Conclusions:
- Three months of antihypertensive therapy positively impacted cognitive function scores in hypertensive patients, particularly in areas of initial impairment.
- The study found no evidence of cognitive deterioration after the 3-month treatment period.
Objectives:
Hypertension is known to be associated with cognitive decline. Many studies revealed that control of hypertension with antihypertensive therapy controls the cognitive decline associated with hypertension. While there are reports that suggest that antihypertensive drugs do not provide protection from cognitive decline, the present study is designed to evaluate the cognitive status of patients recently diagnosed as hypertensive and effect of 3 month long antihypertensive therapy on cognitive functions.
Materials And Methods:
A predesigned pretested questionnaire was used to collect the information. The PGI memory scale (PGIMS) was employed to assess memory function of patients. Baseline memory functions were evaluated before starting the treatment with antihypertensive and compared with the cognitive function scores of healthy volunteers. After the 3 months of treatment, cognitive functions were evaluated again by the same scale. The unpaired t-test was used to compare the cognitive functions between case and control and the paired t-test was used to compare pre- and post-treatment score.
Results:
This study revealed that mean scores of six subtests of cognitive functions were less in cases as compared to subjects in comparison group. After 3 months of antihypertensive therapy, scores of five sub-tests were found to be increased. Among these five subtests, four were those which were found declined at the baseline.
Conclusion:
This suggests that antihypertensive therapy given for 3 months improved the score of those cognitive function tests in which hypertensive patients perform poorly during recruitment and there was no deterioration of any test after 3 months of antihypertensive therapy.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Hypertension III: Clinical Manifestations and Diagnostic Studies
Antihypertensive Drugs: Action of Diuretics